During the past decade, ProMedica Maumee Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ProMedica Maumee Cancer Center" #1 collaborator was "Canadian Cancer Trials Group" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "ProMedica Maumee Cancer Center" are "Breast Carcinoma" (1 trials) and "Node Positive HER2 Negative Breast Cancer" (1 trials). Many other conditions were trialed in "ProMedica Maumee Cancer Center" in a lesser frequency.

Most popular intervention types in "ProMedica Maumee Cancer Center" are "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Health Education Program" (1 trials), "Placebo" (1 trials) and "Weight Loss Intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "ProMedica Maumee Cancer Center" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "ProMedica Maumee Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in ProMedica Maumee Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ProMedica Maumee Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".